Oral Wegovy launched. $149/month. The pill was the hard part… until it wasn't. The next frontier isn't the drug. It's owning the system that determines whether it works: who to treat, when to adjust, how to measure success. That's where the value lives.
https://t.co/qpMEtjuZ1S
106 target trial emulations in oncology. Poor-to-fair agreement with the RCTs they emulated. The TTE framework is sound. The execution rigour is not. Methodology that runs in production - validated, governed, auditable - is what closes this gap.
https://t.co/00ccvH2U4Z
AstraZeneca acquired Modella AI for multimodal biomarker discovery. Multi-modal foundation models and biomarker discovery are now core infrastructure requirements in the modern Biopharma stack.
https://t.co/4Jvw0Yp40z
🚀 Launch end-to-end omics tests 100x faster.
Hurdle’s new platform update makes configuring complex #bioinformatics workflows as simple as software — with built-in reliability & data integrity.
🧬 #Omics, without bottlenecks.
https://t.co/1eMdFSDSWa
From 6 weeks to 24 hours. ⚡
Hurdle’s new kitting model slashes product launch times while keeping quality and compliance high — giving Pathway clients the speed to seize market opportunities.
📦 #Faster. #Smarter. #Scalable.
Full article 👇
https://t.co/D6tviepEgG
Meet Us at Association for Diagnostics & Laboratory Medicine 2025 @myADLM in Chicago, July 27th to 31st 🌆
Hurdle’s Commercial Co-Founder, Charles Ball, will be on the ground at #ADLM2025 (formerly AACC) next week!
#Diagnostics is no longer a test—it’s a system.
At #ASCO25 & #AACR25, multimodal tools like cfDNA fragmentomics & AI-led decision platforms took centre stage.
We’re building the infra to make these plug-and-play.
We talk about diagnostics as gateways to precision medicine—but what happens before and after the test?
Dr Tom Stubbs, PhD from Hurdle explores why closing the loop matters.
📖 https://t.co/h5fHwib8eu
#PrecisionMedicine#Diagnostics#CarePathways#Biotech
We're delighted to have Felice from Hurdle heading to #hlth2025 in Amsterdam!
HLTH is always a fantastic conference for connecting with businesses and individuals who are innovating in the health space.
Drop us a DM to organise a chat!
#networking#healthtech#biotech
We've released a new article on actionable Customer Feedback;
1️⃣ Why feedback is the most underutilised growth tool
2️⃣ How to turn comments into action, not just reports
3️⃣ How our test return process improved through real feedback
#cx#biotech#diagnostics#customers
Our May Hurdle Edition is here! 📣
Last month we looked at:
→ Instant phlebotomy bookings
→ Closing the loop on diagnostics
→ Building feedback-driven products
This is diagnostics that do more than deliver a result.
#diagnostics#biomarkers#phlebotomy#clinicalpathways
Heading to #ASCO25 in Chicago? 🏙️
Dr. Tom Stubbs (CEO) and Dr. Daniel Elías Martín Herranz (CSO) will be will be on the ground at @ASCO 2025 in Chicago.
Tom and Daniel are available to dig into how Hurdle is bringing a fresh perspective to precision #oncology
Fantastic article featured on @pharmaphorum from our very own Emma Stone on how US tariffs are likely to effect the MedTech supply chain.
Full article 👇
https://t.co/ITYB65Kndq
Clinical pathways are moving closer to home. This is enhancing patient care, removing barriers and cutting costs.
Dive into Dr. Adam Abbs' insights on this transformative shift.
Read more: https://t.co/nxz23JhxOs
#Healthcare#RemoteCare#DigitalHealth#NHS#Health